title: Enzyme replacement therapies: better lives versus the bottom line.
abstract: On the highest end of the drug-cost spectrum, enzyme replacement therapies are beneficial to only a few thousand patients at most. But to give those with life-long struggles a chance at a 'normal existence,' can insurers and employers put a price on hope? The field is booming, making the question more important with each passing day.
authors: John
authors: J
authors: Carroll